Spots Global Cancer Trial Database for TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN
Official Title:
Study ID: NCT00539630
Conditions
Interventions
Study Description
Brief Summary: To describe the clinical response rate in two groups (Docetaxel plus cisplatin plus 5-FU, versus Cisplatin plus 5-FU) after 3 cycle of neoadjuvant chemotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sanofi-Aventis, Seoul, , Korea, Republic of
Contact Details
Name: Hyang Rim Kim
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
